Comparative study of contents of several bioactive components in fruiting bodies and mycelia of culinary-medicinal mushrooms

International Journal of Medicinal Mushrooms

Volumn 15, Issue 3, 2013, Pages 315-323

  Lin, Shin Yi ^a   Chen, Yu Kai ^a   Yu, Hui Tzu ^a   Barseghyan, Gayane S ^b   Asatiani, Mikheil D ^b   Wasser, Solomon P ^b,c   Mau, Jeng Leun ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b UNIVERSITY OF HAIFA   (Israel)

^c M G KHOLODNY INSTITUTE OF BOTANY   (Ukraine)

Author keywords

Culinary medicinal mushrooms; Ergothioneine; GABA; Lovastatin

Indexed keywords

4 AMINOBUTYRIC ACID; MEVINOLIN; THIONEINE;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BIOLOGICAL ACTIVITY; CALIBRATION; CYATHUS; DRY WEIGHT; FRUITING BODY; FUNGAL BIOMASS; LIPID PEROXIDATION; MEDICINAL MUSHROOM; MYCELIUM; NONHUMAN; PLEUROTUS;

AGARICALES; ERGOTHIONEINE; FRUITING BODIES, FUNGAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; LOVASTATIN; MYCELIUM;

AGARICUS; AGROCYBE; BASIDIOMYCOTA; COPRINUS; CORDYCEPS; CYATHUS; CYATHUS STRIATUS; FLAMMULINA; FOMES; GANODERMA; GRIFOLA; LAETIPORUS; LENTINUS; MORCHELLA; PLEUROTUS; PLEUROTUS CORNUCOPIAE; TRAMETES; TREMELLA; VERPA;

EID: 84876961783     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v15.i3.80     Document Type: Article

References (28)

1. Ulziijargal E, Mau JL. Nutrient compositions of culinary-medicinal mushroom fruiting bodies and mycelia. Int J Med Mushrooms. 2011;13:343-49.
2. Wasser SP. Medicinal mushroom science: history, current status, future trends, and unsolved problems. Int J Med Mushrooms. 2010;12:1-16.
3. Lo YC, Lin SY, Ulziijargal E, Chen SY, Chien RC, Tzou YJ, Mau JL. Comparative study of contents of several bioactive components in fruiting bodies and mycelia of culinary-medicinal mushrooms. Int J Med Mushrooms. 2012;14:357-63.
4. Chen SY, Ho KJ, Hsieh YJ, Wang LT, Mau JL. Contents of lovastatin, γ-aminobutyric acid and ergothioneine in mushroom fruiting bodies and mycelia. Food Sci Technol. 2012;47:274-78.
5. Aarons CB, Cohen PA, Gower A, Reed KL, Leeman SE, Stucchi AF, Becker JM. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg. 2007;245:176-84.
6. Shizuka F, Kido Y, Nakazawa T, Kitajima H, Aizawa C, Kayamura H, Ichijo N. Antihypertensive effect of γ-amino butyric acid enriched soy products in spontaneously hypertensive rats. Biofactors. 2004;22:165-67.
7. Tsuji K, Ichikawa T, Tanabe N, Abe S, Tarui S, Nakagawa Y. Effects of two kinds of koji on blood pressure in spontaneously hypertensive rats. Nippon Nogeikagaku Kaishi. 1992;66:1241-46.
8. Ey J, Schomig E, Taubert D. Dietary sources and antioxidant effects of ergothioneine. J Agric Food Chem. 2007;55:6466-74.
9. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet. 2003;35:341-48.
10. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, Newman B, Oene MV, Cescon D, Greenberg G, Griffiths AM, George-Hyslop PHS, Siminovitch KA. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet. 2004;36:471-75.
11. Franzoni F, Colognato R, Galetta F, Laurenza I, Barsotti M, Di Stefano R, Bocchetti R, Regoli F, Carpi A, Balbarini A, Migliore L, Santoro G. An in vitro study on the free radical scavenging capacity of ergothioneine: comparison with reduced glutathione, uric acid and trolox. Biomed Pharmacother. 2006;60:453-57.
12. Yang JH, Tseng YH, Chang HL, Lee YL, Mau JL. Storage stability of monascal adlay. Food Chem. 2004;90:303-9.
13. Mau JL, Chyau CC, Li JY, Tseng YH. Flavor compounds in straw mushrooms Volvariella volvacea harvested at different stages of maturity. J Agric Food Chem. 1997;45:4726-29.
14. Dubost NJ, Beelman RB, Peterson D, Royse DJ. Identification and quantification of ergothioneine in cultivated mushrooms by liquid chromatography-mass spectroscopy. Int J Med Mushrooms. 2006;8:215-22.
15. Alarcon J, Aguila S, Arancibia-Avila P, Fuentes O, Zamorano-Ponce E, Hernandez M. Production and purification of statins from Pleurotus ostreatus (Basidiomycetes) strains. Z Naturforsch. 2003;58C:62-64.
16. Lee JW, Lee SM, Gwak KS, Lee JY, Choi IG. Screening of edible mushrooms for the production of Lovastatin and its HMG-CoA reductase inhibitory activity. Korean J Microbiol. 2006;42:83-88.
17. Lindequist U, Niedermeyer THJ, Jülich WD. The pharmacological potential of mushrooms. Evid Based Complement Alternat Med. 2005;2:285-99.
18. Tsai SY, Tsai HL, Mau JL. Nonvolatile taste components of fruit bodies and mycelia of shaggy ink cap mushroom Coprinus comatus (O.F. Müll.: Fr.) Pers. (Agaricomycetideae). Int J Med Mushrooms. 2007;9:47-55.
19. Tsai SY, Tsai HL, Mau JL. Non-volatile taste components of Agaricus blazei, Agrocybe cylindracea and Boletus edulis. Food Chem. 2008;107:977-83.
20. Genghof DS. Biosynthesis of ergothioneine and hercynine by fungi and Actinomycetales. J Bacteriol. 1970;103:475-78.
21. Dubost NJ, Ou B, Beelman RB. Quantification of polyphenols and ergothioneine in cultivated mushrooms and correlation to total antioxidant capacity. Food Chem. 2007;105:727-35.
22. Chen SY, Ho KJ, Liang CH, Tsai CH, Huang LY, Mau JL. Preparation of culinary-medicinal king oyster mushroom Pleurotus eryngii-fermented products with high ergothioneine content and their taste quality. Int J Med Mushrooms. 2012;14:85-93.
23. Borghi C, Veronesi M, Bacchelli S, Esposti DD, Cosentino E, Ambrosioni E. Serum cholesterol levels, blood pressure response to stress and incidence of stable hypertension in young subjects with high normal blood pressure. J Hypertens. 2004;22:265-72.
24. Chopra V, Choksi PU, Cavusoglu E. Beyond lipid lowering: the anti-hypertensive role of statins. Cardiovasc Drug Ther. 2007;21:161-69.
25. Das UN. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis. 2008;15:7-37.
26. Tang JL, Wang WZ, An JG, Hu YH, Cheng SH, Griffiths S. How willing are the public to pay for anti-hypertensive drugs for primary prevention of cardiovascular disease: a survey in a Chinese city. Int J Epidemiol. 2009;39:1-11.
27. Aruoma OI, Spencer JPE, Mahmood N. Protection against oxidative damage and cell death by the natural antioxidant ergothioneine. Food Chem Toxicol. 1999;37:1043-53.
28. Paul BD, Snyde SH. The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death Differ. 2009;17:1-7.